

In the modern pharmaceutical landscape, delivering reliable, high-quality oral solid dosage formulations is essential for effective patient care. Among the diverse spectrum of anti-infective therapies, Doxycycline and Lactic Acid Bacillus Capsules represent a widely recognized combination formulated to support targeted antibiotic treatment while addressing gut microbiome stability. Arozia Care, a quality-conscious pharmaceutical company, offers this essential combination under the brand name DOXYGLOR LB.
When healthcare professionals prescribe antibiotic therapy, maintaining pharmaceutical standards in formulation and stability is critical. Antibiotics play a fundamental role in managing various bacterial infections; however, systemic antimicrobial action can temporarily alter normal intestinal flora. By combining a broad-spectrum tetracycline antibiotic with beneficial spore-forming lactic acid bacteria, Doxycycline and Lactic Acid Bacillus Capsules provide a balanced pharmaceutical presentation. Arozia Care is dedicated to supplying healthcare providers and distributors with professionally formulated medicines like DOXYGLOR LB that meet stringent manufacturing standards.
Doxycycline and Lactic Acid Bacillus Capsules are a fixed-dose solid oral pharmaceutical preparation containing two complementary active components: doxycycline synthesized as an active antibiotic agent and Lactic Acid Bacillus (often formulated as Lactobacillus sporogenes or Bacillus coagulans) as a probiotic spore component.
The primary antimicrobial component, doxycycline, is a second-generation tetracycline derivative. It works by inhibiting bacterial protein synthesis, thereby stopping the growth and replication of susceptible microorganisms. Concurrently, the inclusion of Lactic Acid Bacillus serves to introduce viable microflora spores into the gastrointestinal environment. Because oral antibiotic therapy can inadvertently disrupt the delicate balance of beneficial gut bacteria, incorporating probiotic spores into Doxycycline and Lactic Acid Bacillus Capsules offers a dual-action therapeutic design within a single oral unit.
Through DOXYGLOR LB, Arozia Care presents this dual formulation in a convenient, uniform capsule shell, ensuring precise dosage delivery and stability for clinical applications under appropriate medical supervision.
The efficacy and safety profile of any pharmaceutical drug product depend directly on its active composition and formulation integrity. DOXYGLOR LB, manufactured and distributed by Arozia Care, contains a standardized strength of both active ingredients.
| Active Ingredient | Strength / Quantity | Pharmaceutical Category |
| Doxycycline | 100 mg | Tetracycline Class Antibiotic |
| Lactic Acid Bacillus | 60 Million Spores | Probiotic / Spore-Forming Microflora |

In this balanced formulation of DOXYGLOR LB, the 100 mg dose of doxycycline provides the required antimicrobial concentration for indicated susceptible bacterial strains, while the 60 million viable spores of Lactic Acid Bacillus are micro-encapsulated to survive storage and gastric transit.
When evaluating oral solid medications, healthcare practitioners and pharmaceutical partners look for precise formulation parameters, container stability, and consistent bio-equivalence. DOXYGLOR LB reflects Arozia Care‘s focus on professional product presentation and quality assurance.
The primary distinction of DOXYGLOR LB lies in its combination of an antibiotic and a probiotic element within one oral capsule. This design simplifies administration for patients who require antibiotic therapy alongside gut flora support.
The Lactic Acid Bacillus spores utilized in DOXYGLOR LB are selected for their physical resilience. Spore-forming lactic acid bacteria possess naturally protective outer layers that resist heat, moisture, and acidic stomach environments, ensuring that viable spores reach the intestinal tract intact.
Arozia Care prioritizes high-grade blister and strip packaging for Doxycycline and Lactic Acid Bacillus Capsules. Proper moisture barriers and light protection ensure that the antibiotic potency remains uncompromised and the probiotic spore count remains active throughout the product’s shelf life.
Doxycycline is a well-established, broad-spectrum antibiotic belonging to the tetracycline group. Mechanistically, it acts as a bacteriostatic agent by reversibly binding to the 30S ribosomal subunit of susceptible bacteria. This action prevents the access of aminoacyl-tRNA to the mRNA-ribosome complex, effectively halting bacterial protein synthesis and preventing cellular multiplication.
Doxycycline exhibits activity against a wide range of Gram-positive and Gram-negative bacteria, as well as atypical microorganisms such as Mycoplasma pneumoniae, Chlamydia species, and Rickettsia.
Doxycycline is readily absorbed from the upper gastrointestinal tract and possesses a longer biological half-life compared to earlier first-generation tetracyclines. This allows for convenient once- or twice-daily dosing schedules as determined by a prescribing physician. Furthermore, its lipid solubility enables adequate tissue penetration across various anatomical sites.
Because of these pharmacokinetic features, Doxycycline and Lactic Acid Bacillus Capsules are widely utilized across various medical specialties when prescribed by registered medical practitioners.
While broad-spectrum antibiotics are highly effective at neutralizing pathogenic bacteria, their action is not selectively restricted to pathogens. Oral administration of potent antibiotics can reduce the population of beneficial bacteria natively residing in the human gastrointestinal tract.

Lactic Acid Bacillus produces lactic acid within the intestinal lumen. The resulting mild acidification creates an environment that favors the growth of healthy, non-pathogenic microflora while suppressing the overgrowth of unwanted opportunistic organisms.
Unlike standard vegetative probiotic cultures that may rapidly degrade at room temperature or in gastric acid, the spore form of Lactic Acid Bacillus used in DOXYGLOR LB remains dormant until it reaches the favorable environment of the intestine. There, the spores germinate and temporarily colonize the gut, supporting physiological digestive stability during the period of antibiotic administration.
Prescribed by physicians across multiple therapeutic areas, Doxycycline and Lactic Acid Bacillus Capsules serve as an important therapeutic option for treating susceptible bacterial infections while supporting gastrointestinal comfort.
Under professional medical guidance, DOXYGLOR LB by Arozia Care may be indicated for:
By integrating Lactic Acid Bacillus directly into the capsule, DOXYGLOR LB offers added convenience over co-prescribing separate antibiotic and probiotic products. Patients receive their prescribed antimicrobial therapy alongside protective spore support in one unified dose, encouraging better prescription adherence.
Selecting a reliable pharmaceutical provider is a fundamental consideration for medical professionals, chemists, stockists, and healthcare institutions. Arozia Care has established a strong reputation by emphasizing product quality, therapeutic consistency, and professional commercial support.

Arozia Care operates with a focus on pharmaceutical excellence. From raw material sourcing to final batch testing, products like DOXYGLOR LB undergo rigorous quality checks to confirm active ingredient uniformity, dissolution profiles, and microbial limit compliance.
Recognizing the importance of clear labeling, patient safety, and market demand, Arozia Care ensures that all packaging for Doxycycline and Lactic Acid Bacillus Capsules clearly displays active strengths, storage instructions, batch details, and expiry data.
Whether catering to franchise partners, pharmaceutical distributors, or healthcare networks, Arozia Care provides dependable supply logistics, transparent communication, and business-oriented assistance to support patient access to quality medicines across regions.
Antibiotics are prescription-only medications that must be handled responsibly by both prescribers and patients to maintain therapeutic effectiveness and minimize adverse risks.
Antibiotic resistance is a critical global public health concern. Prescribing Doxycycline and Lactic Acid Bacillus Capsules without a proven or strongly suspected bacterial infection increases the risk of developing drug-resistant bacterial strains. Patients should complete the entire course of DOXYGLOR LB exactly as prescribed by their physician, even if symptoms improve early.

DOXYGLOR LB (Doxycycline and Lactic Acid Bacillus Capsules) is a prescription antibiotic combination used under medical supervision to manage susceptible bacterial infections, such as respiratory tract infections, severe acne, genitourinary tract infections, and specific gastrointestinal or vector-borne conditions.
Doxycycline effectively targets pathogenic bacteria causing infections. However, broad-spectrum antibiotics can also alter normal, beneficial gut flora. The inclusion of Lactic Acid Bacillus introduces resilient probiotic spores that help support normal microflora balance and maintain digestive comfort during antibiotic therapy.
No, it is generally recommended to avoid consuming DOXYGLOR LB directly with milk, dairy products, or antacids containing calcium, aluminum, or magnesium. Doxycycline can bind with calcium and magnesium ions, which significantly reduces its absorption and effectiveness in the body. It is best to space these out by at least 2 hours as advised by a doctor or pharmacist.
The capsules should be swallowed whole with a full glass of water while sitting or standing upright. Remaining upright for at least 30 minutes after swallowing helps prevent esophageal irritation. Always follow the exact dosage, frequency, and duration prescribed by your healthcare provider.
No, tetracycline antibiotics like doxycycline are generally contraindicated during pregnancy, lactation, and in children under 8 years of age because they can permanently discolor developing teeth and affect bone growth.
Yes, doxycycline can cause photosensitivity, making the skin more prone to sunburn. While taking this medication, avoid prolonged or excessive exposure to direct sunlight or tanning beds, use a broad-spectrum sunscreen, and wear protective clothing when going outdoors.
No. Doxycycline is specifically an antibacterial agent. It is not effective against viral infections such as the common cold, influenza, or viral fever. Taking antibiotics when not medically required contributes to antibiotic resistance.
The dual-action formulation of Doxycycline and Lactic Acid Bacillus Capsules represents a practical, patient-focused approach to antibiotic therapy. By pairing 100 mg of broad-spectrum doxycycline with 60 million viable spores of Lactic Acid Bacillus, DOXYGLOR LB offers a balanced pharmaceutical solution designed to target susceptible bacterial infections while supporting intestinal microbial harmony.
As a dedicated pharmaceutical brand, Arozia Care remains committed to offering quality-assured medications, supporting healthcare professionals, and meeting the evolving demands of the pharmaceutical market with integrity and professional care.
Interested in learning more about DOXYGLOR LB or partnering with Arozia Care for pharmaceutical distribution? Contact our dedicated professional support team today to explore our full product portfolio, discuss franchise opportunities, or request detailed pharmaceutical product specifications.